Genetic polymorphisms of CYP2C19 were found to be associated with a greater risk of HCC in Japanese cirrhotic patients with HCV infection 43, as well as a significant risk of triple‐negative breast cancer 44 and lung cancer in combination analysis with smoking in a Chinese population 45. Here, CYP2C19 is linked to lung cancer.